Liver microwave ablation: a systematic review of various FDA-approved systems
- PMID: 30506218
- PMCID: PMC6611060
- DOI: 10.1007/s00330-018-5842-z
Liver microwave ablation: a systematic review of various FDA-approved systems
Abstract
Objectives: The aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.
Methods: A review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.
Results: Thirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r = 0.85, p < 0.001) in contrast to the in vivo experiments (r = 0.54, p = 0.27).
Conclusion: Manufacturers' algorithms on microwave ablation zone sizes are based on preclinical animal experiments with normal liver parenchyma. Clinical data reporting on ablation zone volume in relation to applied energy and sphericity index during MWA are scarce and require more adequate reporting of MWA data.
Key points: • Clinical data reporting on the ablation zone volume in relation to applied energy during microwave ablation are scarce. • Manufacturers' algorithms on microwave ablation zone sizes are based on preclinical animal experiments with normal liver parenchyma. • Preclinical data do not predict actual clinical ablation zone volumes in patients with liver tumors.
Keywords: Ablation techniques; Electromagnetic radiation; Liver diseases; Microwaves; Tumor volume.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation.Int J Hyperthermia. 2017 Feb;33(1):34-42. doi: 10.1080/02656736.2016.1196830. Epub 2016 Jul 25. Int J Hyperthermia. 2017. PMID: 27443519 Clinical Trial.
-
Real-time qualitative MR monitoring of microwave ablation in ex vivo livers.Int J Hyperthermia. 2016 Nov;32(7):757-64. doi: 10.1080/02656736.2016.1204629. Epub 2016 Jul 20. Int J Hyperthermia. 2016. PMID: 27436220
-
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : New advances in interventional oncology: state of the art.Med Oncol. 2017 Apr;34(4):49. doi: 10.1007/s12032-017-0903-8. Epub 2017 Feb 20. Med Oncol. 2017. PMID: 28220346
-
[Microwave ablation of liver tumors as a new instrument for minimally invasive liver surgery].Pol Merkur Lekarski. 2009 May;26(155):545-9. Pol Merkur Lekarski. 2009. PMID: 19606722 Review. Polish.
-
A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma.J Med Ultrason (2001). 2020 Apr;47(2):265-277. doi: 10.1007/s10396-019-00997-5. Epub 2020 Jan 20. J Med Ultrason (2001). 2020. PMID: 31960190 Review.
Cited by
-
Direction of Tissue Contraction after Microwave Ablation: A Comparative Experimental Study in Ex Vivo Bovine Liver.Korean J Radiol. 2022 Jan;23(1):42-51. doi: 10.3348/kjr.2021.0134. Korean J Radiol. 2022. PMID: 34983092 Free PMC article.
-
Efficacy and safety of radiofrequency ablation for secondary hyperparathyroidism: a systematic review and meta-analysis.Asian Biomed (Res Rev News). 2024 Dec 16;18(6):287-296. doi: 10.2478/abm-2024-0036. eCollection 2024 Dec. Asian Biomed (Res Rev News). 2024. PMID: 39697216 Free PMC article.
-
MR-Guided High-Power Microwave Ablation in Hepatic Malignancies: Initial Results in Clinical Routine.Cardiovasc Intervent Radiol. 2020 Nov;43(11):1631-1638. doi: 10.1007/s00270-020-02584-5. Epub 2020 Jul 22. Cardiovasc Intervent Radiol. 2020. PMID: 32699978 Free PMC article.
-
Microwaves, a potential treatment for bacteria: A review.Front Microbiol. 2022 Jul 25;13:888266. doi: 10.3389/fmicb.2022.888266. eCollection 2022. Front Microbiol. 2022. PMID: 35958124 Free PMC article. Review.
-
Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol.Contemp Clin Trials Commun. 2019 Oct 12;16:100471. doi: 10.1016/j.conctc.2019.100471. eCollection 2019 Dec. Contemp Clin Trials Commun. 2019. PMID: 31701044 Free PMC article.
References
-
- Meijerink MR, Puijk RS, van Tilborg AAJM et al (2018) Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and metaanalysis: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol. 10.1007/s00270-018-1959-3 - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical